Marina Panova-Noeva
Overview
Explore the profile of Marina Panova-Noeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases
Coral D, Smit F, Farzaneh A, Gieswinkel A, Tajes J, Sparso T, et al.
Nat Med
. 2024 Nov;
31(2):695.
PMID: 39572748
No abstract available.
2.
Coral D, Smit F, Farzaneh A, Gieswinkel A, Tajes J, Sparso T, et al.
Nat Med
. 2024 Oct;
31(2):534-543.
PMID: 39448862
Obesity and cardiometabolic disease often, but not always, coincide. Distinguishing subpopulations within which cardiometabolic risk diverges from the risk expected for a given body mass index (BMI) may facilitate precision...
3.
Packer M, Ferreira J, Butler J, Filippatos G, Januzzi Jr J, Gonzalez Maldonado S, et al.
J Am Coll Cardiol
. 2024 Sep;
84(20):1979-1994.
PMID: 39217550
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors exert a distinctive pattern of direct biological effects on the heart and kidney under experimental conditions, but the meaningfulness of these signatures for patients...
4.
Massey R, Chen Y, Panova-Noeva M, Mattheus M, Siddiqui M, Schloot N, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):256.
PMID: 39014446
Background: BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been lacking. Furthermore,...
5.
Baidildinova G, Ten Cate V, Panova-Noeva M, Dahlen B, Gieswinkel A, von Ungern-Sternberg S, et al.
Blood Adv
. 2024 May;
8(15):3870-3874.
PMID: 38776438
No abstract available.
6.
Panova-Noeva M, Koeck T, Schoelch C, Schulz A, Prochaska J, Michal M, et al.
Obesity (Silver Spring)
. 2024 Apr;
32(6):1198-1209.
PMID: 38664310
Objective: The objective of this study was to investigate whether an obesity-related inflammatory protein signature (OIPS) is associated with adverse cardiovascular events. Methods: The Olink Target 96 Inflammation panel was...
7.
Ferreira J, Packer M, Sattar N, Butler J, Gonzalez Maldonado S, Panova-Noeva M, et al.
Eur J Heart Fail
. 2024 Apr;
26(4):806-816.
PMID: 38587259
Aims: Insulin-like growth factor binding protein-7 (IGFBP7) is a biomarker of tissue senescence with a role in cardio-renal pathophysiology. The role of IGFBP7 as a prognostic biomarker across the full...
8.
Ferreira J, Packer M, Sattar N, Butler J, Pocock S, Anker S, et al.
Eur J Heart Fail
. 2024 Mar;
26(4):788-802.
PMID: 38439582
Aim: Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA-125). The role of CA-125 as a biomarker of congestion or for prognosis across the full ejection fraction...
9.
Ferreira J, Butler J, Anker S, Januzzi J, Panova-Noeva M, Reese-Petersen A, et al.
Eur J Heart Fail
. 2023 Dec;
26(2):274-284.
PMID: 38037709
Aims: Extracellular matrix remodelling is one of the key pathways involved in heart failure (HF) progression. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) may have a role in attenuating myocardial fibrosis. The...
10.
Ferreira J, Packer M, Butler J, Filippatos G, Pocock S, Januzzi J, et al.
Eur J Heart Fail
. 2023 Nov;
26(1):155-164.
PMID: 37964408
Aims: Growth differentiation factor-15 (GDF-15) is upregulated in part in response to cardiomyocyte stretch and stress, and it exerts a protective role that is mediated by its action to suppress...